Preview

Артериальная гипертензия

Расширенный поиск

Сосудистое ремоделирование: новые цели - проверенные способы их достижения

https://doi.org/10.18705/1607-419X-2010--2-

Полный текст:

Об авторах

Ю. В. Свиряев
ФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Н. Э. Звартау
ФГУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Список литературы

1. Guidelines for the management of arterial hypertension // Eur. Heart J. - 2007. - Vol. 28, № 12. - P. 1462-1536.

2.

3. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension // J. Hypertens. - 2003. - Vol. 21, № 6. - P. 1011-1053.

4.

5. Chobanian A.V., Bakris G.L., Black H.R. et al.; Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure // Hypertension. - 2003. - Vol. 42, № 6. - P. 1206-1252.

6.

7. Franklin S.S., Khan S.A., Wong N.D., Larson M.G., Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study // Circulation. - 1999. - Vol. 100, № 4. - P. 354-360.

8.

9. Blacher J., Staessen J.A., Girerd X. et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients // Arch. Intern. Med. - 2000. - Vol. 160, № 8. - P. 1085-1089.

10.

11. Kannel W.B., Dawber T.R., McGee D.L. Perspectives on systolic hypertension. The Framingham study // Circulation. - Vol. 61, № 6. - P. 1179 - 1182.

12.

13. Williams B <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Williams%20B%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Lacy P.S <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Lacy%20PS%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>.,

14.

15. Thom S.M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Thom%20SM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>. et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study // Circulation. <javascript:AL_get(this,%20'jour',%20'Circulation.');> - 2006. - Vol. 113, № 9. - P. 1213-1225.

16.

17. Protogerou A.D., Papaioannou T.G., Blacher J., Papamichael C.M., Lekakis J.P., Safar M.E. Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? <http://www.ncbi.nlm.nih.gov/pubmed/17211229?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=23> // J. Hypertens. - 2007. - Vol. 25, № 2. - P. 265-272.

18.

19. Pini R., Cavallini M.C., Palmieri V. et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study // J. Am. Coll. Cardiol. - 2008. - Vol. 51, № 25. - P. 2432-2439.

20.

21. Laurent S., Cocroft J. Central aortic blood pressure. - Elservier, 2008. - 65 p.

22.

23. Савицкий Н.Н. Биофизические основы кровообращения и клинические методы изучения гемодинамики. - Ленинград: «Медицина», Ленинградское отделение, 1974. - 307 с.

24.

25. Blacher J., Guerin A.P <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Guerin%20AP%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Pannier B <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pannier%20B%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Marchais S.J <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Marchais%20SJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Safar M.E <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Safar%20ME%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>.,

26.

27. London G.M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22London%20GM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>. Impact of aortic stiffness on survival in end-stage renal disease // Circulation. <javascript:AL_get(this,%20'jour',%20'Circulation.');> - 1999. - Vol. 99, № 18. - P. 2434-2439.

28.

29. Safar M.E <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Safar%20ME%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Blacher J <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Blacher%20J%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Pannier B <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pannier%20B%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>. et al. Central pulse pressure and mortality in end-stage renal disease // Hypertension. <javascript:AL_get(this,%20'jour',%20'Hypertension.');> - 2002. - Vol. 39, № 3. - P. 735-738.

30.

31. Wang K.L <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Wang%20KL%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Cheng H.M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Cheng%20HM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Sung S.H <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sung%20SH%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>. et al. Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: a community-based study // Hypertension. <javascript:AL_get(this,%20'jour',%20'Hypertension.');> - 2010. - Vol. 55, № 3. - P. 799-805.

32.

33. Boutouyrie P., Tropeano A.I., Asmar R. et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study <http://www.ncbi.nlm.nih.gov/pubmed/11799071?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2> // Hypertension. - 2002. - Vol. 39, № 1. - P. 10-15.

34.

35. Laurent S., Boutouyrie P., Asmar R. et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients <http://www.ncbi.nlm.nih.gov/pubmed/11358934?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=21> // Hypertension. - 2001. - Vol. 37, № 5. - P. 1236-1241.

36.

37. Laurent S., Katsahian S., Fassot C. et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension <http://www.ncbi.nlm.nih.gov/pubmed/12677025?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2> // Stroke. - 2003. - Vol. 34, № 5. - P. 1203-1206.

38.

39. Willum-Hansen T., Staessen J.A., Torp-Pedersen C. et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population <http://www.ncbi.nlm.nih.gov/pubmed/16461839?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=3> // Circulation. - 2006. - Vol. 113, № 5. - P. 664-670.

40.

41. Mitchell G.F., Hwang S.J., Vasan R.S. et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study <http://www.ncbi.nlm.nih.gov/pubmed/20083680?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1> // Circulation. - 2010. - Vol. 121, № 4. - P. 505-511.

42.

43. Liu Z <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Liu%20Z%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Hesse C <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hesse%20C%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>.,

44.

45. Curry T.B <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Curry%20TB%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>. et al. Ambulatory arterial stiffness index is not correlated with the pressor response to laboratory stressors in normotensive human // J. Hypertens. <javascript:AL_get(this,%20'jour',%20'J%20Hypertens.');> - 2009. - Vol. 27, № 4. - P. 763-768.

46.

47. Amar J., Ruidavets J.B., Chamontin B., Drouet L., Ferrières J. Arterial stiffness and cardiovascular risk factors in a population-based study <http://www.ncbi.nlm.nih.gov/pubmed/11288807?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=11> // J. Hypertens. - 2001. - Vol. 19, № 3. - P. 381-387.

48.

49. Caputo L., Tedgui A., Levy B.I. Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats: role of endothelium and flow // Circ. Res. - 1995. - Vol. 77, № 2. - P. 303-309.

50.

51. Wilkinson I.B., Cockcroft J.R., Webb D.J. Pulse wave analysis and arterial stiffness // J. Cardiovasc. Pharmacol. - 1999. - Vol. 32 (Suppl. 3). - P. 33-37.

52.

53. Celermajer D.S. Endothelial dysfunction: does it matter? Is it reversible? // J. Am. Coll. Cardiol. - 1997. - Vol. 30, № 3. - P. 325-333.

54.

55. Glasser S.P., Arnett D.K., McVeigh G.E. et al. Vascular compliance and cardiovascular disease: a risk factor or a marker? // Am. J. Hypertens. - 1997. - Vol. 10, № 10 (Pt. 1). - P. 1175-1189.

56.

57. Steinberg H.O. et al. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans // Circulation. - 1997. - Vol. 96, № 10. - P. 3287-3293.

58.

59. Bayorh M.A., Ganafa A.A., Eatman D., Walton M., Feuerstein G.Z. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension // Am. J. Hypertens. - 2005. - Vol. 18, № 11. - P. 1496-1502.

60.

61. Wang C.Y., Liu P.Y., Liao J.K. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results // Trends Mol. Med. - 2008. - Vol. 14, № 1. - P. 37-44.

62.

63. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization // Circulation. - 2001. - Vol. 103, № 7. - P. 926-933.

64.

65. Fukumoto Y., Libby P., Rabkin E., et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits // Circulation. - 2001. - Vol. 103, № 7. - P. 993-999.

66.

67. Muramatsu J., Kobayashi A., Hasegawa N., Yokouchi S. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin // Atherosclerosis. - 1997. -Vol. 130, № 1-2. - P. 189-182

68.

69. Mahmud A <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mahmud%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Feely J <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Feely%20J%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection // Am. J. Hypertens. <javascript:AL_get(this,%20'jour',%20'Am%20J%20Hypertens.');> - 2008. - Vol. 21, № 6. - P. 663-667.

70.

71. McEniery C.M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22McEniery%20CM%22%5BAuthor%5D>., Schmitt M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Schmitt%20M%22%5BAuthor%5D>., Qasem A <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Qasem%20A%22%5BAuthor%5D>. et al. Nebivolol increases arterial distensibility in vivo // Hypertension. <javascript:AL_get(this,%20'jour',%20'Hypertension.');> - 2004. - Vol. 44, № 3. - P. 305-310.

72.

73. Ritter J.M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ritter%20JM%22%5BAuthor%5D>. Nebivolol: endothelium-mediated vasodilating effect // J. Cardiovasc. Pharmacol. <javascript:AL_get(this,%20'jour',%20'J%20Cardiovasc%20Pharmacol.');> - 2001. - Vol. 38 (Suppl. 3). - P. S13-S16.

74.

75. Zanchetti A <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Zanchetti%20A%22%5BAuthor%5D>. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients // Blood Press. Suppl. <javascript:AL_get(this,%20'jour',%20'Blood%20Press%20Suppl.');> - 2004. - Vol. 1. - P. 17-32.

76.

77. Mackenzie I.S <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mackenzie%20IS%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., McEniery C.M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22McEniery%20CM%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Dhakam Z <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Dhakam%20Z%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Brown M.J <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Brown%20MJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Cockcroft J.R <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Cockcroft%20JR%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>.

78.

79. Weber K.T <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Weber%20KT%22%5BAuthor%5D>. Cardioreparation in hypertensive heart disease // Hypertension. <javascript:AL_get(this,%20'jour',%20'Hypertension.');> - 2001. - Vol. 38, № 3 (Pt. 2). - P. 588-591.

80.

81. Benetos A <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Benetos%20A%22%5BAuthor%5D>., Gautier S <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gautier%20S%22%5BAuthor%5D>., Ricard S <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ricard%20S%22%5BAuthor%5D>. et al. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients // Circulation. <javascript:AL_get(this,%20'jour',%20'Circulation.');> - 1996. - Vol. 94, № 4. - P. 698-703.

82.

83. Castellano M., Mulesan M.L., Rizzoni D. et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in general population: the Vobarno study // Circulation. - 1995. - Vol. 91, № 11. - P. 2721-2724.

84.

85. Bonithon-Kopp C., Ducimetiere P., Touboul P.J. et al. Plasma angiotensin-converting enzyme activity and carotid wall thickening // Circulation. - 1994. - Vol. 89, № 3. - P. 952-954.

86.

87. Mancia G. Angiotensin-converting enzyme inhibitors in the treatment of hypertension <http://www.ncbi.nlm.nih.gov/pubmed/1725194> // J. Cardiovasc. Pharmacol. - 1991. - Vol. 18 (Suppl. 7). - P. S1-S3.

88.

89. Porter K.E <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Porter%20KE%22%5BAuthor%5D>., Turner N.A <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Turner%20NA%22%5BAuthor%5D>. Cardiac fibroblasts: at the heart of myocardial remodeling // Pharmacol. Ther. <javascript:AL_get(this,%20'jour',%20'Pharmacol%20Ther.');> - 2009. - Vol. 123, № 2. - P. 255-278.

90.

91. Bretzel R.G. Protecting the residual renal function: which drugs of choice? <http://www.ncbi.nlm.nih.gov/pubmed/9231893> // Am. J. Hypertens. - 1997. - Vol. 10, № 7 (Pt. 2). - P. 159S-166S.

92.

93. Buléon M., Mehrenberger M., Pécher C. et al. New perspectives for bradykinin in nephroprotection <http://www.ncbi.nlm.nih.gov/pubmed/18154717> // Med. Sci. (Paris). - 2007. - Vol. 23, № 12. - P. 1141-1147.

94.

95. Werner C.M., Böhm M. The therapeutic role of RAS blockade in chronic heart failure <http://www.ncbi.nlm.nih.gov/pubmed/19124420> // Ther. Adv. Cardiovasc. Dis. - 2008. - Vol. 2, № 3. - P. 167-177.

96.

97. Weir M.R <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Weir%20MR%22%5BAuthor%5D>. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? // Clin. Ther. <javascript:AL_get(this,%20'jour',%20'Clin%20Ther.');> - 2007. - Vol. 29, № 9. - P. 1803-1824.

98.

99. Werner C <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Werner%20C%22%5BAuthor%5D>., Baumhдkel M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Baumh%C3%A4kel%20M%22%5BAuthor%5D>., Teo K.K <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Teo%20KK%22%5BAuthor%5D>. et al. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection // Clin. Res. Cardiol. <javascript:AL_get(this,%20'jour',%20'Clin%20Res%20Cardiol.');> - 2008. - Vol. 97, № 7. - P. 418-431.

100.

101. Asmar R <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Asmar%20R%22%5BAuthor%5D>., Topouchian J <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Topouchian%20J%22%5BAuthor%5D>., Pannier B <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pannier%20B%22%5BAuthor%5D>., Benetos A <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Benetos%20A%22%5BAuthor%5D>., Safar M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Safar%20M%22%5BAuthor%5D>. Scientific, quality control, coordination and investigation committees of the Complior Study <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Scientific%2C%20Quality%20Control%2C%20Coordination%20and%20Investigation%20Committees%20of%20the%20Complior%20Study%22%5BCorporate%20Author%5D>. Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, quality control, coordination and investigation committees of the Complior Study // J. Hypertens. <javascript:AL_get(this,%20'jour',%20'J%20Hypertens.');> - 2001. - Vol. 19, № 4. - P. 813-818.

102.

103. Hirata K <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hirata%20K%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Vlachopoulos C <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Vlachopoulos%20C%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., Adji A <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Adji%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>., O'Rourke M.F <http://www.ncbi.nlm.nih.gov/pubmed?term=%22O'Rourke%20MF%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstract>. Benefits from angiotensin-converting enzyme inhibitor «beyond blood pressure lowering»: beyond blood pressure or beyond the brachial artery? // J. Hypertens. <javascript:AL_get(this,%20'jour',%20'J%20Hypertens.');> - 2005. - Vol. 23, № 3. - P. 551-556.

104.

105. Topouchian J., El Feghali R., Pannier B. et al. Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study) <http://www.ncbi.nlm.nih.gov/pubmed/17969367> // Vasc. Health Risk Manag. - 2007. - Vol. 3, № 4. - P. 381-387.

106.

107. Yusuf S., Sleight P., Pogue J., Davies R., Dagenais G. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcome Prevention Evaluation Study Investigators // N. Engl. J. Med. - 2000. - Vol. 342, № 3. - P. 145-153.

108.

109. Ahimastos A.A., Natoli A.K.., Lawler A., Blombery P.A., Kingwell B.A. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture // Hypertension. - 2005. - Vol. 45, № 6. - P. 1194-1199.


Для цитирования:


Свиряев Ю.В., Звартау Н.Э. Сосудистое ремоделирование: новые цели - проверенные способы их достижения. Артериальная гипертензия. 2010;16(2):181-184. https://doi.org/10.18705/1607-419X-2010--2-

For citation:


Sviryaev Y.V., Zvartau N.E. Vascular remodeling: new aims and their achievement. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2010;16(2):181-184. (In Russ.) https://doi.org/10.18705/1607-419X-2010--2-

Просмотров: 56


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)